Skip to content

Clinical trials

Completed Adenocarcinoma of Lung trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma of Lung Status: Completed Country / region: China Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20123
20131
20153
20161
20171
20182
20192
20204
20212
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fudan University4
Novartis Pharmaceuticals3
Geneplus-Beijing Co. Ltd.2
Sun Yat-sen University2
Guangzhou Medical University1
Maastricht University1
Nanjing University1
Shanghai Chest Hospital1
Shanghai Pulmonary Hospital, Shanghai, China1
Shanghai Zhongshan Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma of Lung21
Lung Neoplasms7
Carcinoma, Non-Small-Cell Lung6
Brain Neoplasms1
Bronchial Neoplasms1
Lung Diseases1
Neoplasm Metastasis1
Neoplasms1
Plasma Cell Granuloma, Pulmonary1
Sleep Disorders, Circadian Rhythm1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.